Their cumulative risk of breast cancer (BC) may be as high as 70% for carriers of both genes, whereas the risk of ovarian cancer (OC) is estimated to be 44% for BRCA1 carriers and 17% for BRCA2 carriers [1]. This evidence concerns the gene BRCA2 and ovarian carcinoma.